(Q41073230)

26 September 2017

1 reference

title

Molecular mechanisms of virus-induced carcinogenesis: the interaction of viral factors with cellular tumor suppressor proteins (English)

1 reference

26 September 2017

1 reference

F Hoppe-Seyler

1

0 references

author name string

K Butz

series ordinal

2

1 reference

26 September 2017

publication date

1 November 1995

1 reference

Journal of Molecular Medicine

26 September 2017

published in

1 reference

26 September 2017

volume

73

1 reference

26 September 2017

issue

11

1 reference

26 September 2017

page(s)

529-538

1 reference

Primary hepatocellular carcinoma

26 September 2017

cites work

1 reference

12 December 2020

Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein

1 reference

12 December 2020

Inhibition of p53-mediated transactivation by E6 of type 1, but not type 5, 8, or 47, human papillomavirus of cutaneous origin.

1 reference

12 December 2020

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis

1 reference

12 December 2020

HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes

1 reference

12 December 2020

Interaction of adenoviral proteins with pRB and p53.

1 reference

12 December 2020

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

12 December 2020

Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein

1 reference

12 December 2020

Viruses in human cancers

1 reference

12 December 2020

p53 status and the efficacy of cancer therapy in vivo

1 reference

12 December 2020

Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering.

1 reference

12 December 2020

Tumor suppressor genes in molecular medicine

1 reference

12 December 2020

Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes

1 reference

12 December 2020

Trans-activator gene of HTLV-II induces IL-2 receptor and IL-2 cellular gene expression.

1 reference

12 December 2020

Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus

1 reference

12 December 2020

p53 mutations increase resistance to ionizing radiation

1 reference

12 December 2020

Biochemical and biological differences between E7 oncoproteins of the high- and low-risk human papillomavirus types are determined by amino-terminal sequences

1 reference

12 December 2020

A SARCOMA OF THE FOWL TRANSMISSIBLE BY AN AGENT SEPARABLE FROM THE TUMOR CELLS

1 reference

12 December 2020

Epidermodysplasia verruciformis: immunological and clinical aspects.

1 reference

12 December 2020

The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes

1 reference

12 December 2020

Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line

1 reference

12 December 2020

Tumor suppressor genes

1 reference

12 December 2020

Heterogeneity of the human papillomavirus group.

1 reference

12 December 2020

EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.

1 reference

12 December 2020

The retinoblastoma protein and cell cycle control

1 reference

12 December 2020

p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes

1 reference

12 December 2020

Cancer. p53, guardian of the genome

1 reference

12 December 2020

Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53

1 reference

12 December 2020

WAF1, a potential mediator of p53 tumor suppression

1 reference

12 December 2020

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

1 reference

12 December 2020

The p53 tumor-suppressor gene

1 reference

12 December 2020

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

12 December 2020

A human temperature-sensitive p53 mutant p53Val-138: modulation of the cell cycle, viability and expression of p53-responsive genes.

1 reference

12 December 2020

Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product

1 reference

12 December 2020

HBx gene of hepatitis B virus induces liver cancer in transgenic mice

1 reference

12 December 2020

Structural rearrangement of integrated hepatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatic tissues

1 reference

12 December 2020

DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2

1 reference

12 December 2020

Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents

1 reference

12 December 2020

Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I.

1 reference

12 December 2020

The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein

1 reference

12 December 2020

A p53-dependent mouse spindle checkpoint

1 reference

12 December 2020

Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells.

1 reference

12 December 2020

The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis.

1 reference

12 December 2020

Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53.

1 reference

12 December 2020

Gene therapy for cancer

1 reference

12 December 2020

Functional p53 protein in human papillomavirus-positive cancer cells.

1 reference

12 December 2020

Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma

1 reference

12 December 2020

Sequence-specific transcriptional activation is essential for growth suppression by p53.

1 reference

12 December 2020

Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells

1 reference

12 December 2020

Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity

1 reference

12 December 2020

DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control

1 reference

12 December 2020

Stable expression of the tax gene of type I human T-cell leukemia virus in human T cells activates specific cellular genes involved in growth

1 reference

12 December 2020

Inhibitors of mammalian G1 cyclin-dependent kinases

1 reference

12 December 2020

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

12 December 2020

Integrated hepatitis B virus X and 3' truncated preS/S sequences derived from human hepatomas encode functionally active transactivators

1 reference

12 December 2020

Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation

1 reference

12 December 2020

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

1 reference

12 December 2020

p53-mediated cellular response to DNA damage in cells with replicative hepatitis B virus

1 reference

12 December 2020

Participation of p53 protein in the cellular response to DNA damage

1 reference

12 December 2020

p53 function and dysfunction

1 reference

12 December 2020

Diversity of hepatitis B virus X gene-related transcripts in hepatocellular carcinoma: a novel polyadenylation site on viral DNA

1 reference

12 December 2020

Papillomaviruses and cancer of the upper digestive and respiratory tracts.

1 reference

12 December 2020

Functions of human papillomavirus proteins.

1 reference

12 December 2020

Interactions between papillomavirus proteins and tumor suppressor gene products.

1 reference

12 December 2020

Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes

1 reference

12 December 2020

Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.

1 reference

12 December 2020

Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types

1 reference

12 December 2020

Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53

1 reference

12 December 2020

Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53

1 reference

12 December 2020

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

1 reference

12 December 2020

Estimates of the worldwide incidence of eighteen major cancers in 1985.

1 reference

12 December 2020

Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency

1 reference

12 December 2020

Papillomaviruses in human disease: Part II. Molecular biology and immunology of papillomavirus infections and carcinogenesis

1 reference

12 December 2020

Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins.

1 reference

12 December 2020

Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1.

1 reference

12 December 2020

Functional inactivation but not structural mutation of p53 causes liver cancer.

1 reference

12 December 2020

Stabilization of the tumor suppressor p53 during cellular transformation by simian virus 40: influence of viral and cellular factors and biological consequences

1 reference

12 December 2020

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

1 reference

12 December 2020

The association of Epstein-Barr virus (EBV) with T cell lymphoproliferations and Hodgkin's disease: two new developments in the EBV field

1 reference

12 December 2020

Hepatitis B virus. The major etiology of hepatocellular carcinoma

1 reference

12 December 2020

Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells

1 reference

12 December 2020

Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA

1 reference

12 December 2020

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

1 reference

12 December 2020

Evidence for a second cell cycle block at G2/M by p53.

1 reference

12 December 2020

Activation of Epstein-Barr virus replication in Hodgkin and Reed-Sternberg cells

1 reference

12 December 2020

The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator

1 reference

12 December 2020

Biologic aspects of AIDS-related lymphoma

1 reference

12 December 2020

Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3

1 reference

12 December 2020

Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease

1 reference

12 December 2020

Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells

1 reference

12 December 2020

The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation

1 reference

12 December 2020

Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development

1 reference

12 December 2020

Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00195138

1 reference

26 September 2017

1 reference